LifeMD, Inc.
LFMD • NASDAQ
LifeMD, Inc. is a medical - pharmaceuticals company in the healthcare sector trading on NASDAQ, led by CEO Justin Schreiber, with a market cap of $178.5M.
CEOJustin Schreiber
Next Earnings
Upcoming earnings announcement for LifeMD, Inc.
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.13
Revenue Estimate
$48.5M
Earnings History
Past 12 earnings reports for LifeMD, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.04Est: $0.02 | -300.0% | $46.9MEst: $45.1M | +4.0% |  10-K |
| Nov 17, 2025 | Q3 2025 | -$0.07Est: $0.01 | -800.0% | $60.2MEst: $62.2M | -3.3% | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.06Est: $0.10 | -160.0% | $62.2MEst: $66.3M | -6.1% | 10-Q |
| May 6, 2025 | Q1 2025 | $0.01Est: $0.14 | -92.9% | $65.7MEst: $62.5M | +5.2% | 10-Q |
| Mar 10, 2025 | Q4 2024 | $0.21Est: -$0.05 | +520.0% | $64.3MEst: $57.4M | +12.0% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.09Est: -$0.12 | +175.0% | $53.4MEst: $53.8M | -0.8% | 10-Q |
| Aug 7, 2024 | Q2 2024 | $0.06Est: -$0.12 | +150.0% | $50.7MEst: $48.3M | +5.0% | 10-Q |
| May 8, 2024 | Q1 2024 | $0.01Est: -$0.15 | +106.7% | $44.1MEst: $42.5M | +3.8% | 10-Q |
| Mar 11, 2024 | Q4 2023 | $0.15Est: -$0.14 | +207.1% | $44.9MEst: $40.5M | +10.8% | 10-K |
| Nov 8, 2023 | Q3 2023 | $0.08Est: -$0.15 | +153.3% | $38.6MEst: $38.2M | +1.2% | — |
| Aug 9, 2023 | Q2 2023 | $0.05Est: -$0.10 | +150.0% | $35.9MEst: $35.2M | +2.2% | 10-Q |
| May 12, 2023 | Q1 2023 | $0.06Est: -$0.16 | +137.5% | $33.1MEst: $30.8M | +7.6% | — |